In a recently released study by Indian Council of Medical Research (ICMR), Congenital Hypothyroidism affects 1 in 1172 newborn babies in India. This figure is highly alarming when compared to worldwide statistics of 1 in 3,800 newborn babies. In such a situation, it is extremely essential to screen newborns to ensure early detection & diagnosis of the disease. Trivitron Healthcare, India's largest Medical Technology Company, pioneers the most cost effective 'Newborn Screening' tests in India. Congenital Hypothyroidism' is a condition in newborn babies that is caused due to the deficiency of thyroid hormones. In newborn babies, thyroid hormones are extremely important for brain development and overall growth. This defect cannot be pointed out unless newborns are tested for the deficiency. Indeed, most newborn babies with Congenital Hypothyroidism appear normal at birth, even if there is complete lack of development of the thyroid gland. This is because a small amount of thyroid hormone (T4) from the mother is transferred to the baby during pregnancy. Thus, 'Neonatal Screening' or 'Newborn Screening' for the early detection of the thyroid hormones deficiency is extremely crucial for all newborns.

Visit Site